Natixis Bristol Myers Squibb CO Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Natixis holds 1,353,813 shares of BMY stock, worth $81.1 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

1,353,813

Previous 1,593,931 15.06%

Holding current value

$81.1 Million

Previous $66.2 Million 5.84%

% of portfolio

0.4%

Previous 0.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $9.52 Million - $12.4 Million	-240,118 Reduced 15.06%	1,353,813 $70.1 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $64.2 Million - $84.5 Million	1,593,931 New	1,593,931 $66.2 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $7.68 Million - $9.17 Million	158,441 New	158,441 $8.13 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $54.5 Million - $60.5 Million	854,960 Added 192.66%	1,298,735 $83.1 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $61.8 Million - $70.1 Million	-940,060 Reduced 67.93%	443,775 $30.8 Million
Q4 2022 Feb 24, 2023	SELL	$68.48 - $81.09 $322 Million - $381 Million	-4,703,335 Reduced 77.27%	1,383,835 $99.6 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $6.97 Million - $8.26 Million	101,829 Added 1.7%	6,087,170 $438 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $39,956 - $23.6 Million	307,361 Added 5.41%	5,985,341 $430 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $355 Million - $391 Million	4,885,184 Added 616.2%	5,677,980 $436 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $1.33 Million - $1.59 Million	-21,560 Reduced 2.65%	792,796 $57.9 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $21 Million - $24.4 Million	390,789 Added 92.26%	814,356 $50.8 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $28 Million - $32.8 Million	-473,723 Reduced 52.79%	423,567 $25.1 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $12.9 Million - $14.1 Million	-209,038 Reduced 18.89%	897,290 $59.5 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $10.5 Million - $11.8 Million	-176,290 Reduced 13.74%	1,106,328 $69.8 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $74.1 Million - $83.9 Million	1,282,618 New	1,282,618 $79.6 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $60.4 Million - $67 Million	-1,052,049 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $24.2 Million - $28.2 Million	-440,693 Reduced 29.52%	1,052,049 $61.9 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $31.9 Million - $46.4 Million	687,686 Added 85.42%	1,492,742 $83.2 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $30.8 Million - $40.2 Million	625,735 Added 348.95%	805,056 $51.3 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $12.4 Million - $14.7 Million	-290,217 Reduced 61.81%	179,321 $9.09 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $9.97 Million - $11 Million	223,551 Added 90.88%	469,538 $21.3 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $16.4 Million - $19.6 Million	-364,237 Reduced 59.69%	245,987 $11.8 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $4.79 Million - $6.22 Million	98,333 Added 19.21%	610,224 $31.7 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $9.05 Million - $10.2 Million	-163,969 Reduced 24.26%	511,891 $31.8 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $809,541 - $1.01 Million	-16,021 Reduced 2.32%	675,860 $37.1 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $4.49 Million - $5.17 Million	74,903 Added 12.14%	691,881 $43.5 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $23.6 Million - $25.7 Million	392,997 Added 175.46%	616,978 $37.8 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $2.17 Million - $2.51 Million	-39,324 Reduced 14.93%	223,981 $14.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	263,305	263,305 $14.7 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $127B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account